http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9808013-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4995
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D337-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 1998-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6471ab0fdfb65cad09a79375edd331ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11051db850c038874035409a66e56f7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65c00509844c5a920b9872366afb354
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb2dbb1145340f3c77d791954d9e9875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab1911d37d944fc0492094245c03dea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c37324969042f7c45319079150dbca05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41fc380a17dd2a143f76a074d6854a9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e436dd597875b18caff92bb7a23af3cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21537460e0eb9c03f4ca0ca54fbf78a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4dea1f74cae9c9b9830ef4ef0897df7
publicationDate 2001-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9808013-A
titleOfInvention Combination therapy employing ileal bile acid transport inhibiting benzothiepines and co-a hmg reductase inhibitors
abstract Invention Patent: <B> COMBINATION THERAPY USING "ILEAL" BILIARY ACID TRANSPORT INHIBITION BENZOTIEPINS AND HMG CO-A "REDUCTASE INHIBITORS <D>. New benzothiepines, derivatives and their analogues are provided; and methods of using these compounds and compositions in medicine, particularly in the prophylaxis and treatment of hyperlipidemic conditions such as those associated with atherosclerosis or hypercholesterolemia, in mammals. Compositions and methods for combination therapy employing transport inhibitors are also provided. "ileal" bile acid and HMG Co-A reductase inhibitors for the treatment of hyperlipidemic conditions.
priorityDate 1997-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9834037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420138017

Total number of triples: 58.